Sakamakon gwaje-gwajen Amurka da Turai na Glucosamine
A Cibiyar Harkokin Kimiyya ta Harkokin Kimiyya ta Jami'ar Amirka (2005), an gabatar da gwajin glucosamine guda biyu. Sakamakon gwaje-gwaje guda biyu sunyi tsammanin masu bincike, likitoci, da marasa lafiya suke neman tabbatarwa cewa glucosamine wani zaɓi ne mai dacewa don maganin arthritis .
- Cibiyar GAIT (Glucosamine / Chondroitin Arithritis Intervention Trial) ta tallafa wa Cibiyoyin Lafiya ta Ƙasar da aka tsara don ƙayyade aminci da inganci tare da glucosamine da chondroitin , an ɗauka daban ko tare.
- GASKIYA (Glucosamine Unum A Cikin Ƙarƙashin Ƙarƙashin Ƙari) wata jarrabawa ce ta Turai.
GAIT (Glucosamine / Chondroitin Arithritis Intervention Trial) Phase I
A GAIT (Glucosamine / Chondroitin Arithritis Intervention Trial), kusan mutane 1,600 tare da ciwo mai zafi na osteoarthritis sun karbi daga ɗaliban makarantun rheumatology na jami'ar Amurka 18 don nazarin. Mahalarta masu nazarin sun sami ciwo mai tsanani kuma suna da shaidar rayukan x-rayus na osteoarthritis. A lokacin binciken GAIT, marasa lafiya:
- An kiyasta a farkon binciken.
- An kimanta shi a makonni 4, 8, 16, 24.
- An samu marasa lafiya don samun glucosamine HCl, sodium chondroitin sulfate, dukansu kari, celecoxib (sunan Celebrex) , ko placebo.
- An bar marasa lafiya har zuwa mita 4,000 na yau da kullum na acetaminophen.
Sakamako Daga GAIT (Glucosamine / Chondroitin Arthritis Intervention Trial)
- Sakamakon ya nuna cewa hada haɗin glucosamine da chondroitin ya fi placebo amma amfanin yana da alaka da tsananin zafi.
- A cikin marasa lafiya da ciwo mai tsananin ciwon osteoarthritis mai tsanani, 79.2% shan glucosamine / chondroitin haɗuwa ta sami jinƙai mai zafi.
- Ga marasa lafiya ɗauke da celecoxib, 69.4% shawo kan jin zafi. Daga marasa lafiya da ke shan glucosamine kawai, 65.7% gudunmawar taimako, kamar yadda 61.4% na marasa lafiya ke daukar chondroitin kadai. Har ila yau, 54,3% na sanya placebo bayar da rahoton taimako mai zafi.
- A cikin marasa lafiya tare da ciwon gwiwa na ciwon osteoarthritis, glucosamine / chondroitin haɗuwa ba ya fi tasiri fiye da placebo ba.
GASKIYA (Glucosamine Unum A Ƙarƙashin Ƙari)
Akwai marasa lafiya 318 a cikin nazarin GUIDE da osteoarthritis na gwiwa (88% mata). Magunguna sun kasance bazuwar su dauki ko dai glucosamine sulfate mai narkewa foda (1500 MG sau ɗaya a rana), acetaminophen (1000 MG sau uku a rana), ko kuma placebo a tsawon watanni 6. Dukkan kungiyoyin sun yarda su dauki ibuprofen kamar yadda ake bukata.
Sakamako Daga GASKIYA (Glucosamine Unum A Cikin Ƙarƙashin Ƙari)
- Dukansu glucosamine sulfate da acetaminophen sun fi tasiri a rage rage zafi fiye da placebo.
- Maganin shan glucosamine sulfate sun nuna jin dadi fiye da marasa lafiya a kan acetaminophen.
- An ƙaddara cewa sau ɗaya-kullum 1500 Mg maganin glucosamine sulfate na iya zama magani da aka fi so ga gwiwa osteoarthritis.
Sakamako na II da kuma Sakamakon Phase III GAIT
Sakamako daga wani lokaci na biyu na nazarin GAIT an wallafa a cikin mujallar Arthritis & Rheumatism a shekarar 2008. Phase II ta tantance hadewar glucosamine da chondroitin don hana haɗin gwiwa na gwiwa. Haɗuwa da glucosamine da chondroitin bai kasance da tasiri ba wajen hana haɗuwa da haɗuwa da osteoarthritis fiye da placebo.
Masu nazarin mahalarta wadanda suka rasa adadin sararin samaniya a tsawon shekaru biyu sun kasance cikin kungiyoyin da suka dauki glucosamine ko chondroitin kadai. Zai yiwu, ɗaukar nauyin biyu tare da rinjayar sha, wanda zai iya bayyana ƙananan tasiri na kari idan an yi amfani dashi.
Mataki na III, wanda yayi la'akari da kimanin shekaru hudu na bayanan, ya bayyana cewa kariyar haɗuwa ko kuma shi kadai ba shi da wani ƙarin amfani ga jin daɗin jin zafi na gwiwa fiye da celecoxib ko placebo. An buga wannan sakamakon a 2010 a cikin mujallar Annals of Rheumatic Disease .
Shawarwarin na ga Glucosamine
- Kafin yin kokarin glucosamine / chondroitin tattauna shi tare da likitan ka kuma tambayi yadda zai dace da shirinka na yau da kullum.
- Tsaya a kan magungunan ku. Abubuwa ba su maye gurbin wajan likitan ku.
- Koyi game da glucosamine ta yin binciken kanka. Nemo samo asali na abin da ke dogara.
- Bi umarnin da mai ƙayyade mai ƙayyade ya ƙayyade ko tambayi likita game da sashi dace.
- Ka guji hada hade da sauran abubuwa.
- Saya daga mai sayarwa mai daraja. San abin da kake samun.
Layin Ƙasa
A shekarar 2012, Cibiyar Kwalejin Rheumatology ta Amirka ta wallafa takardun magani don maganin osteoarthritis. A cikin jagororin, ba a bada shawarar yin amfani da chondroitin ko glucosamine don maganin farko na osteoarthritis. Chondroitin da glucosamine sun hada da kadai ko a hade bazai zama magani mai mahimmanci ga duk marasa lafiya ba. Yana iya aiki ga wasu marasa lafiya, kuma idan yana aiki a gare ku, ci gaba da magani - an dauke shi lafiya.
Sources:
Sakamakon glucosamine da / ko chondroitin sulfate a kan ci gaba na gwiwa osteoarthritis: rahoton daga glucosamine / chondroitin arthritis shigar da fitina. Sawitzke et al. Arthritis & Rheumatism. 2008 Oktoba; 58 (10): 3183-91.
http://www.ncbi.nlm.nih.gov/pubmed/18821708
Glucosamine / Chondroitin Arithritis Intervention Trial (GAIT). NIH. An gyara Janairu 2012.
https://nccih.nih.gov/research/results/gait
Amfani da kwayar cutar glucosamine, chondroitin sulphate, haɗuwa, celecoxib ko placebo da aka yi don magance osteoarthritis na gwiwa: sakamakon shekaru 2 daga GAIT. Yuni 2010. Annals of the Rheumatic Disease. 2010; 69: 1459-1464
http://ard.bmj.com/content/69/8/1459.abstract?sid=fc95aeb7-1d79-4a79-9dac-c65916ca2125
Shawarwari don Amfani da Magungunan Dabbobin Kwayoyin Kwafi da Kwayoyin Kimiyya na Osteoarthritis na Hand, Hip, da Knee.American College of Rheumatology 2012. (Binciken Arthritis & Research Vol. 64, No. 4, Afrilu 2012, shafi na 465-474.)